970 related articles for article (PubMed ID: 23726800)
1. Protective effect of zinc supplementation against cadmium-induced oxidative stress and the RANK/RANKL/OPG system imbalance in the bone tissue of rats.
Brzóska MM; Rogalska J
Toxicol Appl Pharmacol; 2013 Oct; 272(1):208-20. PubMed ID: 23726800
[TBL] [Abstract][Full Text] [Related]
2. The involvement of oxidative stress in the mechanisms of damaging cadmium action in bone tissue: a study in a rat model of moderate and relatively high human exposure.
Brzóska MM; Rogalska J; Kupraszewicz E
Toxicol Appl Pharmacol; 2011 Feb; 250(3):327-35. PubMed ID: 21129391
[TBL] [Abstract][Full Text] [Related]
3. Enhanced zinc consumption prevents cadmium-induced alterations in lipid metabolism in male rats.
Rogalska J; Brzóska MM; Roszczenko A; Moniuszko-Jakoniuk J
Chem Biol Interact; 2009 Jan; 177(2):142-52. PubMed ID: 18848534
[TBL] [Abstract][Full Text] [Related]
4. Effect of zinc supplementation on bone metabolism in male rats chronically exposed to cadmium.
Brzóska MM; Rogalska J; Galażyn-Sidorczuk M; Jurczuk M; Roszczenko A; Kulikowska-Karpińska E; Moniuszko-Jakoniuk J
Toxicology; 2007 Jul; 237(1-3):89-103. PubMed ID: 17560002
[TBL] [Abstract][Full Text] [Related]
5. Reversal of cadmium-induced oxidative stress in rat erythrocytes by selenium, zinc or their combination.
Messaoudi I; Hammouda F; El Heni J; Baati T; Saïd K; Kerkeni A
Exp Toxicol Pathol; 2010 May; 62(3):281-8. PubMed ID: 19464157
[TBL] [Abstract][Full Text] [Related]
6. Effect of zinc supplementation on glutathione peroxidase activity and selenium concentration in the serum, liver and kidney of rats chronically exposed to cadmium.
Galażyn-Sidorczuk M; Brzóska MM; Rogalska J; Roszczenko A; Jurczuk M
J Trace Elem Med Biol; 2012 Jan; 26(1):46-52. PubMed ID: 22100499
[TBL] [Abstract][Full Text] [Related]
7. RANKL/RANK/OPG system and bone status in females with anorexia nervosa.
Ostrowska Z; Ziora K; Oświęcimska J; Swiętochowska E; Szapska B; Wołkowska-Pokrywa K; Dyduch A
Bone; 2012 Jan; 50(1):156-60. PubMed ID: 22001124
[TBL] [Abstract][Full Text] [Related]
8. Berberine alleviates oxidative stress in rats with osteoporosis through receptor activator of NF-kB/receptor activator of NF-kB ligand/osteoprotegerin (RANK/RANKL/OPG) pathway.
He XF; Zhang L; Zhang CH; Zhao CR; Li H; Zhang LF; Tian GF; Guo MF; Dai Z; Sui FG
Bosn J Basic Med Sci; 2017 Nov; 17(4):295-301. PubMed ID: 29055350
[TBL] [Abstract][Full Text] [Related]
9. Cadmium retention increase: a probable key mechanism of the protective effect of zinc on cadmium-induced toxicity in the kidney.
Jihen el H; Fatima H; Nouha A; Baati T; Imed M; Abdelhamid K
Toxicol Lett; 2010 Jul; 196(2):104-9. PubMed ID: 20394811
[TBL] [Abstract][Full Text] [Related]
10. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.
Chiba Y; Onouchi T; Ikeda T; Adachi J; Tamura Y; Horiuchi T
Gerontology; 2009; 55(3):275-80. PubMed ID: 19158438
[TBL] [Abstract][Full Text] [Related]
11. Circadian concentrations of free testosterone, selected markers of bone metabolism, osteoprotegerin and its ligand sRANKL in obese postmenopausal women.
Ostrowska Z; Kos-Kudła B; Marek B; Kajdaniuk D; Wołkowska-Pokrywa K
Postepy Hig Med Dosw (Online); 2011 Oct; 65():658-67. PubMed ID: 22100799
[TBL] [Abstract][Full Text] [Related]
12. Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-kappaB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton.
Mountzios G; Dimopoulos MA; Bamias A; Papadopoulos G; Kastritis E; Syrigos K; Pavlakis G; Terpos E
Acta Oncol; 2007; 46(2):221-9. PubMed ID: 17453373
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of zinc supplementation on blood antioxidant defense system in rats exposed to cadmium.
Jemai H; Messaoudi I; Chaouch A; Kerkeni A
J Trace Elem Med Biol; 2007; 21(4):269-73. PubMed ID: 17980818
[TBL] [Abstract][Full Text] [Related]
14. Iron chelation therapy in Upper Egyptian transfusion-dependent pediatric homozygous beta-thalassemia major: impact on serum L-carnitine/free fatty acids, osteoprotegerin/the soluble receptor activator of nuclear factor-kappabeta ligand systems, and bone mineral density.
Hamed EA; Mohamed NA; El-Metwally TH; Kamal MM
J Pediatr Hematol Oncol; 2010 May; 32(4):267-73. PubMed ID: 20445416
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of receptor activator of NF-kappaB ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients.
Franchimont N; Reenaers C; Lambert C; Belaiche J; Bours V; Malaise M; Delvenne P; Louis E
Clin Exp Immunol; 2004 Dec; 138(3):491-8. PubMed ID: 15544627
[TBL] [Abstract][Full Text] [Related]
16. Changes in the serum levels of osteoprotegerin and soluble receptor activator for nuclear factor kappaB ligand after estrogen-progestogen therapy and their relationships with changes in bone mass in postmenopausal women.
Kim JG; Kim JH; Lee DO; Kim H; Kim JY; Suh CS; Kim SH; Choi YM
Menopause; 2008; 15(2):357-62. PubMed ID: 17925661
[TBL] [Abstract][Full Text] [Related]
17. Interrelationships between cadmium, zinc and antioxidants in the liver of the rat exposed orally to relatively high doses of cadmium and zinc.
Jihen el H; Sonia S; Fatima H; Mohamed Tahar S; Abdelhamid K
Ecotoxicol Environ Saf; 2011 Oct; 74(7):2099-104. PubMed ID: 21726901
[TBL] [Abstract][Full Text] [Related]
18. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant enzymes activity and lipid peroxidation in liver and kidney of rats exposed to cadmium and ethanol.
Jurczuk M; Brzóska MM; Moniuszko-Jakoniuk J; Gałazyn-Sidorczuk M; Kulikowska-Karpińska E
Food Chem Toxicol; 2004 Mar; 42(3):429-38. PubMed ID: 14871584
[TBL] [Abstract][Full Text] [Related]
20. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones.
Ikeda T; Utsuyama M; Hirokawa K
J Bone Miner Res; 2001 Aug; 16(8):1416-25. PubMed ID: 11499864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
